In the present study, we were inspired by the systematic research of Li et al.; they reported that IGF2BP1/2/3, YTHDF1/3, HNRNPA2B1, and VIRMA exhibited copy number variations in amplification across 33 cancer types. Here, VIRMA is linked to cancer.